Cambridge NeuroTech

Cambridge NeuroTech
Name	Cambridge NeuroTech
Industry	Biotechnology
Founded	2015
Founders	David Clifton; Sarah Gilbert
Headquarters	Cambridge, England
Products	Electrode arrays; Neurostimulation devices; Neural recording systems

Cambridge NeuroTech is a British biotechnology company specializing in neural interface hardware and electrophysiology instrumentation. The firm develops microelectrode arrays, neural probes, and supporting software for academic laboratories, clinical research, and pharmaceutical testing. Its activities intersect with neuroscience, neurosurgery, and neuromodulation communities across Europe, North America, and Asia.

History

Cambridge NeuroTech traces origins to collaborations between the University of Cambridge, Wellcome Trust, and spinouts linked to the Medical Research Council and European Research Council grants. Early teams included researchers associated with Addenbrooke's Hospital, Cambridgeshire research institutes, and the Babraham Institute. Founders drew on prior work from groups at Harvard University, Massachusetts Institute of Technology, Stanford University, University College London, and Imperial College London. Seed funding involved investors from Wellcome Trust ventures and venture capital firms connected to Oxford Sciences Innovation and Cambridge Enterprise. Subsequent growth saw strategic partnerships with manufacturers in Germany, Sweden, and Japan and business development with distributors tied to Johnson & Johnson, Medtronic, and Boston Scientific channels. The company expanded its patent portfolio through filings with the European Patent Office and the United States Patent and Trademark Office, and participated in European Union framework projects including Horizon 2020 and collaborations with European Molecular Biology Laboratory affiliates.

Products and Technology

Cambridge NeuroTech's product range includes silicon and polymer microelectrode arrays, reusable multichannel amplifiers, and chronic implant systems used in preclinical and translational research. Instruments are designed to interface with platforms from Neuroscience Research Australia, Roche, Eli Lilly, Pfizer, and academic labs at Johns Hopkins University, Columbia University, and University of California, San Francisco. Proprietary fabrication methods draw on microelectromechanical systems technologies pioneered at ETH Zurich and IMEC. Software stacks offer compatibility with data acquisition systems from National Instruments, Tucker-Davis Technologies, and Blackrock Neurotech. Packaging and biocompatible coatings reference protocols standardized by ISO consortia and draw on materials science research from Max Planck Society laboratories and CERN-linked engineering groups.

Research and Collaborations

Research programs involve partnerships with clinical teams at Addenbrooke's Hospital, academic units at King's College London, and consortia with Karolinska Institutet and KU Leuven. Collaborative projects include neuroprosthetics studies with investigators from University of Oxford, neurodegeneration projects with University College London Hospitals and pharmacology trials with GlaxoSmithKline and AstraZeneca. Cambridge NeuroTech co-authored papers with scientists at MIT, Caltech, Yale University, Princeton University, Cold Spring Harbor Laboratory, and Scripps Research and contributed hardware to brain-computer interface trials coordinated by teams from Brown University and Northwestern University. Grant support has involved the Wellcome Trust, NIH, European Research Council, and philanthropic funders such as the Bill & Melinda Gates Foundation and The Rockefeller Foundation.

Manufacturing and Facilities

Manufacturing is distributed across specialist facilities in Cambridge (UK), precision fabs in Germany near Munich, and cleanroom assembly sites in Singapore supporting Asia-Pacific markets. Quality systems align with standards from the British Standards Institution and certifications recognized by the Medicines and Healthcare products Regulatory Agency and US Food and Drug Administration. Supply-chain arrangements include component sourcing from firms in Taiwan, South Korea, and Switzerland, and logistics partnerships with DHL, FedEx, and UPS. Prototyping collaborations have used fabrication services at CERN-affiliated technology transfer offices and electron-beam lithography facilities tied to Fraunhofer Society centers.

Commercial Activities and Market Presence

Cambridge NeuroTech markets devices to academic research centers including University of Cambridge, University of Edinburgh, University of Manchester, and University of Toronto as well as clinical research units at Massachusetts General Hospital, Mayo Clinic, and Karolinska University Hospital. Sales and distribution channels include regional partners such as VWR International and Fisher Scientific, and reseller agreements with Thermo Fisher Scientific affiliates. The company attends trade shows and conferences like Society for Neuroscience, Federation of European Neuroscience Societies meetings, Neurotechnology Industry Organization events, and the Royal Society lecture series to engage with investors from Index Ventures and Sequoia Capital. Market positioning targets electrophysiology, brain-computer interfaces, and preclinical neuromodulation research niches.

Regulatory, Safety, and Ethical Issues

Regulatory oversight engages agencies including the Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration for device classifications and investigational device exemptions. Ethical review processes have involved institutional review boards at Addenbrooke's Hospital and Guy's and St Thomas' NHS Foundation Trust, and bioethical consultation with scholars from University of Oxford and King's College London. Safety testing follows standards promulgated by BSI and international harmonization bodies such as International Organization for Standardization committees and the International Electrotechnical Commission. The company participates in policy discussions with organizations like Wellcome Trust and the Nuffield Council on Bioethics concerning human enhancement debates and data governance with stakeholders including European Data Protection Board representatives.

Awards and Recognition

Cambridge NeuroTech and its personnel have received awards and recognition from institutions and programs such as the Royal Society Innovation Prize, Innovate UK grants, European Research Council proof-of-concept awards, and regional honors from Cambridge Enterprise. Individual engineers and scientists have been invited to present at the Royal Institution and received fellowships from the Wellcome Trust, Gates Cambridge Scholarship, and named lectureships at King's College London and University of Cambridge.

Category:Biotechnology companies of the United Kingdom